Search

everythinglearnresearchcommunity

for

Search:↓

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Fat cells are important for tissue repair and stem cell support in various body parts.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Hormones during pregnancy and lactation keep skin stem cells inactive, preventing hair growth.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

Treat hair loss with finasteride, minoxidil, or surgery; consider side effects and severity.

Asian hair is generally straight and thick, with unique disorders and properties, and more research is needed to understand it fully.

Androgens may block hair growth signals, targeting this could treat hair loss.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Eating glucoraphanin can help prevent psychosis in offspring whose mothers had immune system activation.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Stress and alcohol affect brain chemicals differently in rats, mice, and humans, influenced by genetic differences.

Type I interferons play a key role in the development of various skin diseases.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

17-β-Estradiol applied to the skin stops hair growth, while ICI 182 780 helps hair grow in mice.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Menopause affects hair and skin; more research needed for treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.